Smith & Nephew plc (LON:SN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,091.00
-5.00 (-0.46%)
Aug 17, 2026, 3:40 PM GMT

Smith & Nephew Revenue

Smith & Nephew had revenue of $3.10B USD in the half year ending June 27, 2026, with 9.55% growth. This brings the company's revenue in the last twelve months to $6.30B, up 5.99% year-over-year. In the year 2025, Smith & Nephew had annual revenue of $6.16B with 6.09% growth.

Revenue (ttm)
$6.30B
Revenue Growth
+5.99%
P/S Ratio
1.93
Revenue / Employee
$370.59K
Employees
17,000
Market Cap
9.22B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.16B354.00M6.09%
Dec 31, 20245.81B261.00M4.70%
Dec 31, 20235.55B334.00M6.40%
Dec 31, 20225.22B3.00M0.06%
Dec 31, 20215.21B652.00M14.30%
Dec 31, 20204.56B-578.00M-11.25%
Dec 31, 20195.14B234.00M4.77%
Dec 31, 20184.90B139.00M2.92%
Dec 31, 20174.77B96.00M2.06%
Dec 31, 20164.67B35.00M0.76%
Dec 31, 20154.63B17.00M0.37%
Dec 31, 20144.62B266.00M6.11%
Dec 31, 20134.35B214.00M5.17%
Dec 31, 20124.14B-133.00M-3.11%
Dec 31, 20114.27B308.00M7.77%
Dec 31, 20103.96B190.00M5.04%
Dec 31, 20093.77B-29.00M-0.76%
Dec 31, 20083.80B432.00M12.82%
Dec 31, 20073.37B590.00M21.23%
Dec 31, 20062.78B227.00M8.89%
Dec 31, 20052.55B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
AstraZeneca46.25B
GSK plc33.20B
Haleon11.15B
Hikma Pharmaceuticals2.58B
Convatec Group1.88B
Spire Healthcare Group1.58B
CVS Group692.80M
Genus672.00M
Revenue Rankings